Duchenne muscular Dystrophy (DMD)
Showing 1 - 25 of 2,238
Duchenne Muscular Dystrophy Trial in Chengdu (JWK007 Single intravenous infusion administration)
Recruiting
- Duchenne Muscular Dystrophy
- JWK007 Single intravenous infusion administration
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 29, 2023
Duchenne Muscular Dystrophy Trial in Portland (NS-089/NCNP-02)
Not yet recruiting
- Duchenne Muscular Dystrophy
-
Portland, OregonShriners Hospital for Children
Aug 16, 2023
Peabody Developmental Motor Scaling In Period Duchenne Muscular
Completed
- Duchenne Muscular Dystrophy (DMD)
- Peabody Developmental Motor Scales-2, PDMS
-
Samsun, TurkeyOndokuz Mayıs University
Aug 6, 2023
Duchenne Muscular Dystrophy Trial in Little Rock (RGX-202)
Recruiting
- Duchenne Muscular Dystrophy
- RGX-202
-
Little Rock, ArkansasArkansas Children's Hospital
Jan 12, 2023
Duchenne Muscular Dystrophy Trial in Paris (Cardiac MRI, Blood assays)
Not yet recruiting
- Duchenne Muscular Dystrophy
- Cardiac MRI
- Blood assays
-
Paris, FranceNecker Hospital
Sep 26, 2022
Duchenne Muscular Dystrophy Trial (NS-050/NCNP-03, Placebo)
Not yet recruiting
- Duchenne Muscular Dystrophy
- NS-050/NCNP-03
- Placebo
- (no location specified)
Sep 19, 2023
Duchenne Muscular Dystrophy Trial (delandistrogene moxeparvovec)
Not yet recruiting
- Duchenne Muscular Dystrophy
- delandistrogene moxeparvovec
- (no location specified)
Nov 8, 2023
Duchenne Muscular Dystrophy (DMD) Trial in United States (Bocidelpar, Placebo)
Terminated
- Duchenne Muscular Dystrophy (DMD)
- Bocidelpar
- Placebo
-
Sacramento, California
- +4 more
Nov 23, 2022
Evaluation of Home Based Assessments on Participants With DMD
Recruiting
- Duchenne Muscular Dystrophy
- Wearable Device
- Duchenne Video Assessment (DVA)
-
Charlestown, MassachusettsSolid Biosciences
Dec 12, 2022
Duchenne Muscular Dystrophy Trial in Seoul (EN001)
Recruiting
- Duchenne Muscular Dystrophy
-
Seoul, Korea, Republic ofSamsung Medical Center
May 12, 2022
Duchenne Muscular Dystrophy, Exon 44 Trial in San Antonio (AOC 1044, Placebo)
Recruiting
- Duchenne Muscular Dystrophy
- Exon 44
- AOC 1044
- Placebo
-
San Antonio, TexasWorldwide Clinical Trials (Part A only)
Jan 2, 2023
Duchenne Muscular Dystrophy Trial in Columbus (SRP-9001)
Active, not recruiting
- Duchenne Muscular Dystrophy
- SRP-9001
-
Columbus, OhioNationwide Children's Hospital
Jul 4, 2022
DMD-Associated Dilated Cardiomyopathy Trial in Jerusalem, Ramat Gan (talfirastide)
Recruiting
- DMD-Associated Dilated Cardiomyopathy
-
Jerusalem, Israel
- +1 more
Aug 31, 2023
Duchenne Muscular Dystrophy Trial in Pittsburgh (Armon Ayura (Kinova), JAECO Wrex)
Terminated
- Duchenne Muscular Dystrophy
- Armon Ayura (Kinova)
- JAECO Wrex
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Jan 27, 2022
AFFINITY BEYOND: Anti-AAV8 Antibody Assessment Study of Boys
Recruiting
- Duchenne Muscular Dystrophy
- AAV8 DetectCDx
-
Atlanta, GeorgiaRare Disease Research
Jan 12, 2023
Duchenne Muscular Dystrophy (DMD) Trial in Gainesville (Prednisone, In-home Exercise Training, Prednisone plus exercise)
Recruiting
- Duchenne Muscular Dystrophy (DMD)
- Prednisone
- +2 more
-
Gainesville, FloridaUniversity of Florida
Feb 28, 2022
Duchenne Muscular Dystrophy Trial in Vancouver (Vamorolone)
Recruiting
- Duchenne Muscular Dystrophy
-
Vancouver, British Columbia, CanadaBritish Columbia Children's Hospital
Mar 24, 2022
Muscular Dystrophy, Duchenne Trial in United States (SRP-9001)
Enrolling by invitation
- Muscular Dystrophy, Duchenne
- SRP-9001
-
Palo Alto, California
- +4 more
Sep 28, 2022
Monitor Activity Using Wearable Sensors in Duchenne Muscular
Terminated
- Duchenne Muscular Dystrophy (DMD)
- Activity Monitor
-
Columbus, OhioNationwide Children's Hospital
Oct 14, 2021
Quality and Independence of Gait Classification Scale for DMD
Completed
- Duchenne Muscular Dystrophy
- Gait Disorders in Children
- Quality and Independence of Gait Classification Scale for Duchenne Muscular Dystrophy (QIGS-DMD)
-
Isparta, TurkeyGüllü Aydın Yağcıoğlu
Sep 29, 2022
Duchenne Muscular Dystrophy (DMD) Trial in Kagoshima, Tokyo (NS-089/NCNP-02)
Active, not recruiting
- Duchenne Muscular Dystrophy (DMD)
-
Kagoshima, Japan
- +1 more
Nov 16, 2021
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
Not yet recruiting
- Duchenne Muscular Dystrophy
- wearable technology
-
Nashville, TennesseeVanderbilt University Medical Center
Nov 3, 2023
Hyperglycemia and HRV in DMD - Longitudinal Aim
Not yet recruiting
- Duchenne Muscular Dystrophy
- wearable technology
-
Nashville, TennesseeVanderbilt University Medical Center
Oct 16, 2023
Duchenne Muscular Dystrophy, Cardiomyopathy, Dilated Trial in Beijing (Bisoprolol Fumarate)
Recruiting
- Duchenne Muscular Dystrophy
- Cardiomyopathy, Dilated
- Bisoprolol Fumarate
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital
Sep 27, 2022
Duchenne Muscular Dystrophy Trial in Canada, United States (NS-065/NCNP-01, Placebo)
Completed
- Duchenne Muscular Dystrophy
- NS-065/NCNP-01
- Placebo
-
Sacramento, California
- +6 more
Nov 12, 2021